Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 May;75(5):1024-6.
doi: 10.1016/s0015-0282(01)01749-6.

A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction

R Boostanfar  1 , J K Jain, D R Mishell Jr, R J Paulson
Affiliations
Free article
Clinical Trial

A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction

R Boostanfar et al. Fertil Steril. 2001 May.
Free article

Abstract

Objective: To compare the rates of ovulation and pregnancy after tamoxifen citrate (TMX) or clomiphene citrate (CC) among anovulatory women with infertility.

Design: Prospective randomized trial.

Setting: Infertility clinic in a university teaching hospital.

Patient(s): Eighty-six anovulatory women under 40 years of age undergoing ovulation induction.

Intervention(s): The women were assigned randomly to receive either TMX or CC on cycle days 5-9.

Main outcome measure(s): Rates of ovulation and pregnancy for the two treatment modalities.

Results(s): The overall rate of ovulation in the TMX group was 50 of 113 (44.2%) and in the CC group, 41 of 91 (45.1%). There were 10 pregnancies in the TMX group and 6 pregnancies in the CC group. The cycle fecundity per ovulatory cycle was 20.0% in the TMX group and 14.6% in the CC group.

Conclusion(s): The overall rate of ovulation and pregnancy were similar with TMX and CC. TMX is a suitable alternative agent to CC in the management of anovulatory infertility.

PubMed Disclaimer

LinkOut - more resources